J05AR08 emtricitabine, tenofovir disoproxil and rilpivirine
ATC group of level 5 – chemical substance · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 2 medicines in this group.
- 1 prescription only (POM)
- 1 no longer supplied or not available
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
- J05AR Antivirals for treatment of HIV infections, combinations 80 medicines
- J05AR08 emtricitabine, tenofovir disoproxil and rilpivirine 2 medicines
- J05AR Antivirals for treatment of HIV infections, combinations 80 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
Active substances in the group
- Emtricitabine 2 medicines
- Rilpivirine 2 medicines
- Tenofovir disoproxil 2 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Emtricitabine/rilpivirine/tenofovir Disoproxil Gilead 200 mg/25 mg/245 mg film-coated tablets SPC | Prescription only (POM) |
| Eviplera SPC no longer supplied | – |
Other groups of the same level
- J05AR01 zidovudine and lamivudine 3 medicines
- J05AR02 lamivudine and abacavir 12 medicines
- J05AR03 tenofovir disoproxil and emtricitabine 15 medicines
- J05AR04 zidovudine, lamivudine and abacavir 2 medicines
- J05AR06 emtricitabine, tenofovir disoproxil and efavirenz 12 medicines
- J05AR09 emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat 1 medicine
- J05AR10 lopinavir and ritonavir 6 medicines
- J05AR13 lamivudine, abacavir and dolutegravir 1 medicine
- J05AR14 darunavir and cobicistat 2 medicines
- J05AR15 atazanavir and cobicistat 2 medicines
- J05AR16 lamivudine and raltegravir 1 medicine
- J05AR17 emtricitabine and tenofovir alafenamide 10 medicines
- J05AR18 emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat 2 medicines
- J05AR19 emtricitabine, tenofovir alafenamide and rilpivirine 2 medicines
- J05AR20 emtricitabine, tenofovir alafenamide and bictegravir 2 medicines
- J05AR22 emtricitabine, tenofovir alafenamide, darunavir and cobicistat 1 medicine
- J05AR24 lamivudine, tenofovir disoproxil and doravirine 1 medicine
- J05AR25 lamivudine and dolutegravir 1 medicine
Other names of the ATC group
- Czech: J05AR08 Emtricitabin, tenofovir-disoproxil a rilpivirin
- French: J05AR08 emtricitabine, ténofovir disoproxil et rilpivirine
- German: J05AR08 Emtricitabin, Tenofovirdisoproxil und Rilpivirin
- Spanish: J05AR08 EMTRICITABINA. TENOFOVIR DISOPROXIL Y RILPIVIRINA
- German: J05AR08 Emtricitabin, Tenofovirdisoproxil und Rilpivirin
- Italian: J05AR08 EMTRICITABINA, TENOFOVIR DISOPROXIL E RILPIVIRINA
- Polish: J05AR08 EMTRICITABIN, TENOFOVIR-DISOPROXIL I RILPIVIRIN
- Turkish: J05AR08 emtrisitabin, tenofovir disoproksil ve rilpivirin
- Portuguese (Brazil): J05AR08 Emtricitabina + Rilpivirina + Tenofovir
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AR08
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.